Search research articles
Contact Us
Filters
Showing results (951-960 of 962) with videos related to
Page
of 97
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2016
Research needs in breast cancer
F Cardoso, N Harbeck, C H Barrios, et al.
Immunogenetics
|
June 17, 1999
MIC-A allele profiles and HLA class I associations in Behçet's disease
G R Wallace, D H Verity, L J Delamaine, et al.
British Journal of Cancer
|
August 14, 2014
MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
S Hasegawa, H Eguchi, H Nagano, et al.
The British Journal of Ophthalmology
|
August 30, 2008
Microsatellite analysis of the GLC1B locus on chromosome 2 points to NCK2 as a new candidate gene for normal tension glaucoma
M Akiyama, K Yatsu, M Ota, et al.
Breast Cancer Research and Treatment
|
March 25, 2017
Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)
H Kawaguchi, N Masuda, T Nakayama, et al.
Genomics
|
May 15, 1997
Nucleotide sequence analysis of the HLA class I region spanning the 237-kb segment around the HLA-B and -C genes
N Mizuki, H Ando, M Kimura, et al.
Breast Cancer Research and Treatment
|
October 15, 2013
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
S Ohno, L W C Chow, N Sato, et al.
Breast Cancer Research and Treatment
|
April 1, 2014
Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study)
M Takada, H Ishiguro, S Nagai, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
August 12, 2009
Investigation of the association between the GLC3A locus and normal tension glaucoma in Japanese patients by microsatellite analysis
M Kamio, A Meguro, M Ota, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2025
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial
N Harbeck, S Modi, L Pusztai, et al.
Page
of 97
Search research articles
Search
Showing results (951-960 of 962) with videos related to
Sort By:
Page
of 97
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2016
Research needs in breast cancer
F Cardoso, N Harbeck, C H Barrios, et al.
Immunogenetics
|
June 17, 1999
MIC-A allele profiles and HLA class I associations in Behçet's disease
G R Wallace, D H Verity, L J Delamaine, et al.
British Journal of Cancer
|
August 14, 2014
MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
S Hasegawa, H Eguchi, H Nagano, et al.
The British Journal of Ophthalmology
|
August 30, 2008
Microsatellite analysis of the GLC1B locus on chromosome 2 points to NCK2 as a new candidate gene for normal tension glaucoma
M Akiyama, K Yatsu, M Ota, et al.
Breast Cancer Research and Treatment
|
March 25, 2017
Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)
H Kawaguchi, N Masuda, T Nakayama, et al.
Genomics
|
May 15, 1997
Nucleotide sequence analysis of the HLA class I region spanning the 237-kb segment around the HLA-B and -C genes
N Mizuki, H Ando, M Kimura, et al.
Breast Cancer Research and Treatment
|
October 15, 2013
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
S Ohno, L W C Chow, N Sato, et al.
Breast Cancer Research and Treatment
|
April 1, 2014
Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study)
M Takada, H Ishiguro, S Nagai, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
August 12, 2009
Investigation of the association between the GLC3A locus and normal tension glaucoma in Japanese patients by microsatellite analysis
M Kamio, A Meguro, M Ota, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2025
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial
N Harbeck, S Modi, L Pusztai, et al.
Page
of 97